KI
BNTX icon

Keystone Investors’s BioNTech BNTX Stock Holding History

Keystone Investors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Buy
+153,466
New +$14.4M 0.76% 33
2024
Q4 		– Sell
-10,678
Closed -$1.27M – 83
2024
Q3 		$1.27M Buy
+10,678
New +$982K 0.09% 52

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Keystone Investors's BNTX Position: Q2 2026 in Review

Keystone Investors opened a new position in BioNTech (BNTX) in Q2 2026: 153,466 shares worth $14.3M. The stake represents 0.76% of the portfolio and ranks #33 among its holdings. This is a return to the name: Keystone Investors previously reported a position in BNTX as recently as Q3 2024.

Keystone Investors first reported a position in BNTX in Q3 2024 and has held it in 2 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Keystone Investors held 153,466 shares of BioNTech worth $14.3M as of Q2 2026.
  • BioNTech was a new Keystone Investors position in Q2 2026.
  • BioNTech made up 0.76% of Keystone Investors's portfolio in Q2 2026, its #33 holding.
  • Keystone Investors first reported a position in BioNTech in Q3 2024 and has held it in 2 quarters since.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Keystone Investors's 13F filing for Q2 2026, filed 14 Aug 2026.